Psychomotor symptoms of depression

American Journal of Psychiatry

Volumn 154, Issue 1, 1997, Pages 4-17

  Sobin, Christina ^a,b   Sackeim, Harold A ^a  

^a Columbia University ^*  (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MOVEMENT; DEPRESSION; DIAGNOSTIC ACCURACY; HUMAN; MOTOR ACTIVITY; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOMOTOR ACTIVITY; SPEECH DISCRIMINATION; SYMPTOMATOLOGY;

EID: 0031016615     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.154.1.4     Document Type: Article

References (146)

1. Kraepelin E: Lectures on Clinical Psychiatry (1904). New York, Hafner, 1968
2. Zilboorg G: A History of Medical Psychology. New York, Norton, 1944
3. Whitwell JR: Historical Notes on Psychiatry. London, Lewis, 1936
4. Rush AJ, Weissenburger JE: Melancholic symptom features and DSM-IV. Am J Psychiatry 1994; 151:489-498
5. Flint AJ, Black SE, Campbell-Taylor I, Gailey GF, Levinton C: Abnormal speech articulation, psychomotor retardation, and subcortical dysfunction in major depression. J Psychiatr Res 1993; 27:309-319
6. Greden JF: Psychomotor monitoring: a promise being fulfilled? J Psychiatr Res 1993; 27:285-287
7. Nelson JG, Charney DS: The symptoms of major depressive illness. Am J Psychiatry 1981; 138:1-13
8. Ulrich G, Harms K: A video analysis of the nonverbal behaviour of depressed patients before and after treatment. J Affect Disord 1985; 9:63-67
9. Wolff EA III, Putnam FW, Post RM: Motor activity and affective illness: the relationship of amplitude and temporal distribution to changes in affective state. Arch Gen Psychiatry 1985; 42:288-294
10. Wehr TA, Muscettola G, Goodwin FK: Urinary 3-methoxy-4-hydroxyphenylglycol circadian rhythm: early timing (phase-advance) in manic-depressives compared with normal subjects. Arch Gen Psychiatry 1980; 37:257-263
11. Foster FG, Kupfer DJ: Psychomotor activity as a correlate of depression and sleep in acutely disturbed psychiatric inpatients. Am J Psychiatry 1975; 132:928-931
12. Kupfer DJ, Weiss BL, Foster G, Detre TP, McPartland R: Psychomotor activity in affective states. Arch Gen Psychiatry 1974; 30: 765-768
13. Jones IH, Pansa M: Some nonverbal aspects of depression and schizophrenia occurring during the interview. J Nerv Ment Dis 1979; 167:402-409
14. Szabadi E, Bradshaw CM, Besson JA: Elongation of pause-time in speech: a simple, objective measure of motor retardation in depression. Br J Psychiatry 1976; 129:592-597
15. Hoffmann GM, Gonze JC, Mendlewicz J: Speech pause time as a method for the evaluation of psychomotor retardation in depressive illness. Br J Psychiatry 1985; 146:535-538
16. Greden JF, Albala AA, Smokler IA, Gardner R, Carroll BJ: Speech pause time: a marker of psychomotor retardation among endogenous depressives. Biol Psychiatry 1981; 16:851-859
17. Nilsonne A: Speech characteristics as indicators of depressive illness. Acta Psychiatr Scand 1988; 77:253-263
18. Hardy P, Jouvent R, Widlocher D: Speech pause time and the retardation rating scale for depression: towards a reciprocal validation. J Affect Disord 1984; 6:123-127
19. Nilsonne A: Acoustic analysis of speech variables during depression and after improvement. Acta Psychiatr Scand 1987; 76: 235-245
20. Kuny S, Stassen HH: Speaking behavior and voice sound characteristics in depressive patients during recovery. J Psychiatr Res 1993; 27:289-307
21. Lapierre YD, Butter HJ: Agitated and retarded depression: a clinical psychophysiological evaluation. Neuropsychpbiology 1980; 6:217-223
22. Weiss AD: The location of reaction time change with sex, motivation and age. J Gerontol 1965; 20:60-64
23. Welford AT: Fundamentals of Skill. London, Methuen, 1968
24. Danev SG, DeWinter CR, Wartna GF: On the relation between reaction and motion times on a choice reaction task. Acta Psychol (Amst) 1971; 55:188-197
25. Knott V, Lapierre L, Griffiths L, de Lugt D, Bakish D: Event-related potentials and selective attention in major depressive illness. J Affect Disord 1991; 23:43-48
26. Weckowicz TE, Tam CN, Mason J, Bay KS: Speed in test performance in depressed patients. J Abnorm Psychol 1978; 87: 578-582
27. Bruder G, Yozawitz A, Berenhaus I, Sutton S: Reaction time facilitation in affective psychotic patients. Psychol Med 1980; 10: 549-554
28. Bulbena A, Berrios GE: Cognitive function in the affective disorders: a prospective study. Psychopathology 1993; 26:6-12
29. Schwartz F, Carr AC, Munich RL, Glauber S, Lesser B, Murray J: Reaction time impairment in schizophrenia and affective illness: the role of attention. Biol Psychiatry 1989; 25:540-548
30. Cornell DG, Suarez R, Bereut S: Psychomotor retardation in melancholic and nonmelandiolic depression: cognitive and motor components. J Abnorm Psychol 1984; 93:150-157
31. Kupfer DJ, Detre TP, Foster G, Tucker GJ, Delgado J: The application of Delgado's telemetric mobility recorder for human studies. Behav Biol 1972; 7:585-590
32. Post RM, Stoddard FJ, Gillin JC, Buchsbaum MS, Runklc DC, Black KE, Bunney WE Jr: Alterations in motor activity, sleep, and biochemistry in a cycling manic-depressive patient. Arch Gen Psychiatry 1977; 34:470-477
33. Kupfer DJ, Foster KG: Sleep and activity in a psychotic depression. J Nerv Ment Dis 1973; 156:341-348
34. Maxwell R: Multivariate statistical methods and classification problems. Br J Psychiatry 1971; 119:121-127
35. Kendell RE: The classification of depressions: a review of contemporary confusion. Br J Psychiatry 1976; 129:15-28
36. Widlocher DJ: Psychomotor retardation: clinical, theoretical and psychometric aspects. Psychiatr Clin North Am 1983; 6:7-43
37. Nilsonne A, Sundberg J, Ternstrom S, Askenfelt A: Measuring the rate of change of voice fundamental frequency in fluent speech during mental depression. J Acoust Soc Am 1988; 83: 716-728
38. Hemsley DR: Attention and information processing in schizophrenia. Br J Soc Clin Psychol 1976; 15:199-209
39. Judd LL: Effect of lithium on mood, cognition, and personality function in normal subjects. Arch Gen Psychiatry 1979; 36:860-866
40. Ghozlan A, Widlocher D: Decision time and movement time in depression: differential effects of practice before and after clinical improvement. Percept Mot Skills 1989; 68:187-192
41. Henry FM: Reaction time-movement correlations. Percept Mot Skills 1961; 12:63-66
42. Bohannon WE, Strauss ME: Reaction-time crossover in psychiatric outpatients. Psychiatry Res 1983; 9:17-22
43. Levinson DF: Skin conductance orienting response in unmedicated RDC schizophrenic, schizoaffective, depressed, and control subjects. Biol Psychiatry 1991; 30:663-683
44. Williams RM, Hemsley DR: Choice reaction time performance in hospitalized schizophrenic patients and depressed patients. Eur Arch Psychiatry Neurol Sci 1986; 236:169-173
45. Posner MI, Boies SJ, Eichelman WH, Taylor RL: Retention of visual and name codes of single letters. J Exp Psychol 1969; 79: 1-16
46. Smith MJ, Brebion G, Banquet JP, Allilaire JF: Experimental evidence for two dimensions of cognitive disorders in depressives. J Psychiatr Res 1994; 28:401-411
47. Chatterjee A, Chakos M, Koreen A, Geisler S, Sheitman B, Woerner M, Kane JM, Alvir J, Lieberman JA: Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am J Psychiatry 1995; 152:1724-1729
48. Cuesta MJ, Peralta V: Are positive and negative symptoms relevant to cross-sectional diagnosis of schizophrenic and schizoaffective patients? Compr Psychiatry 1995; 36:353-361
49. Ball SG, Buchwald AM, Waddell MT, Shekhar A: Depression and generalized anxiety symptoms in panic disorder: implications for comorbidity. J Nerv Ment Dis 1995; 183:304-308
50. Marten PA, Brown TA, Barlow DH, Borkovec TD, Shear MK, Lydiard RB: Evaluation of the ratings comprising the associated symptom criterion of DSM-III-R generalized anxiety disorder. J Nerv Ment Dis 1993; 181:676-682
51. Rickels K, Schweizer E: The treatment of generalized anxiety disorder in patients with depressive symptomatology. J Clin Psychiatry 1993; 54(Jan suppl):20-23
52. Hecht H, von Zerssen D, Krieg C, Possl J, Wittchen HU: Anxiety and depression: comorbidity, psychopathology, and social functioning. Compr Psychiatry 1989; 30:420-433
53. Piletz JE, DeMet E, Gwirtsman HE, Halaris A: Disruption of circadian MHPG rhythmicity in major depression. Biol Psychiatry 1994; 35:830-842
54. Moffoot AP, O'Carroll RE, Bennie J, Carroll S, Dick H, Ebmeier KP, Goodwin GM: Diurnal variation of mood and ncuropsychological function in major depression with melancholia. J Affect Disord 1994; 32:257-269
55. Avery D, Silverman J: Psychomotor retardation and agitation in depression: relationship to age, sex and response to treatment. J Affect Disord 1984; 7:67-76
56. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278-296
57. Winokur G, Morrison J, Clancy J, Crowe R: The Iowa 500: familial and clinical findings favor two kinds of depressive illness. Compr Psychiatry 1973; 14:99-106
58. Goldman J, Cote L: Aging of the brain: dementia of the Alzheimer's type, in Principles of Neural Science, 3rd ed. Edited by Kandel ER, Schwartz JH, Jessell TM, Norwalk, Conn, Appleton & Lange, 1991, pp 974-983
59. Kay DW, Garside RF, Beamish P, Roy JR: Endogenous and neurotic syndromes of depression: a factor analytic study of 104 cases: clinical features. Br J Psychiatry 1969; 115:377-388
60. Mendels J, Cochrane C: The nosology of depression: the endogenous-reactive concept. Am J Psychiatry 1968; 124(May suppl): 1-11
61. Klein DF: Endogenomorphic depression: a conceptual and terminological revision. Arch Gen Psychiatry 1974; 31:447-454
62. Kendell RE: The Classification of Depressive Illness: Maudsley Monograph 18. London, Oxford University Press, 1968
63. Kendell RE, Gourlay J: The clinical distinction between psychotic and neurotic depression. Br J Psychiatry 1970; 117:257-260
64. Fleiss JL: Classification of the depressive disorders by numerical typology. J Psychiatr Res 1972; 9:141-153
65. Bhrolchain MN, Brown GW, Harris TO: Psychotic and neurotic depression, 2: clinical characteristics. Br J Psychiatry 1979; 134: 94-107
66. Parker G, Hadzi-Pavlovic D, Boyce P: Endogenous depression as a construct: a quantitative analysis of the literature and a study of clinician judgements. Aust NZ J Psychiatry 1989; 23:357-368
67. Buchwald AM, Rudick-Davis D: The symptoms of major depression. J Abnorm Psychol 1993; 102:197-205
68. Miller KB, Nelson JC: Does the dexamethasone suppression test relate to subtypes, factors, symptoms, or severity? Arch Gen Psychiatry 1987; 44:769-774
69. Young MA, Scheftner WA, Klerman GL, Andreasen NC, Hirschfeld RM: The endogenous subtype of depression: a study of its internal construct validity. Br J Psychiatry 1986; 148:257-267
70. Mendels J: Electroconvulsive therapy and depression, part 3: a method for prognosis. Br J Psychiatry 1965; 111:687-690
71. Nelson JC, Charney DS: Primary affective disorder criteria and the endogenous-reactive distinction. Arch Gen Psychiatry 1980; 37:787-793
72. Joyce PR, Paykel ES: Predictors of drug response in depression. Arch Gen Psychiatry 1989; 46:89-99
73. Overall JE, Hollister LE, Johnson M, Pennington V: Nosology of depression and differential response to drugs. JAMA 1966; 195: 946-948
74. Downing RW, Rickels K: Predictors of amitripryline response in out-patient depressives. J Nerv Ment Dis 1972; 154:248-263
75. White K, White J: Tranylcypromine: patterns and predictors of response. J Clin Psychiatry 1986; 47:380-382
76. Ranelli CJ, Miller RE: Behavioral predictors of amitriptyline response in depression. Am J Psychiatry 1981; 138:30-34
77. Carney MW, Roth P, Garside RI: The diagnosis of depressive syndromes and the prediction of ECT response. Br J Psychiatry 1965; 111:659-674
78. Strian F, Albert W, Klicpera C: Course of depressive mood and psychomotor activation in endogenous depression. Arch Psychiatr Nervenkr 1979; 227:193-206
79. Brandon S, Cowley P, McDonald C, Neville P, Palmer R, Wellstood-Eason S: Electroconvulsive therapy: results in depressive illness from the Leicestershire trial. BMJ Clin Res 1984; 288:22-25
80. Buchan H, Johnstone E, McPherson K, Palmer RL, Crow TJ, Brandon S: Who benefits from electroconvulsive therapy? combined results of the Leicester and Northwick Park trials. Br J Psychiatry 1992; 160:355-359
81. Johnstone EC, Deakin JF, Lawler P, Frith CD, Stevens M, McPherson K, Crow TJ: The Northwick Park electroconvulsive therapy trial. Lancet 1980; 2:1317-1320
82. Clinical Research Centre Division of Psychiatry: The Northwick Park ECT trial: predictors of response to real and simulated ECT. Br J Psychiatry 1984; 144:227-237
83. O'Leary D, Gill D, Gregory S, Shawcross C: Which depressed patients respond to ECT? the Nottingham results. J Affect Disord 1995; 33:245-250
84. Sobin C, Prudic J, Devanand DP, Nobler MS, Sackeim HA: Who responds to electroconvulsive therapy? a comparison of effective and ineffective forms of treatment. Br J Psychiatry 1996; 169:322-328
85. Cummings JL: Depression and Parkinson's disease: a review. Am J Psychiatry 1992; 149:443-454
86. Albert ML, Feldman RG, Willis AL: The "subcortical dementia" of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1974; 37:121-130
87. Jeste DV, Karson CN, Wyatt RJ: Movement disorders and psychopathology, in Neuropsychiatric Movement Disorders. Edited by leste DV, Wyatt RJ. Washington, DC, American Psychiatric Press, 1984, pp 119-150
88. Jankovic J, Ford J: Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol 1983; 13:402-411
89. Tolosa ES, Lai C: Meige disease: striatal dopaminergic preponderance. Neurology 1979; 29:1126-1130
90. Akil M, Schwartz JA, Dutchak D, Yuzbasiyan-Gurkan V, Brewer GJ: The psychiatric presentations of Wilson's disease. J Neuropsychiatry Clin Neurosci 1991; 3:377-382
91. Dening TR, Berrios GE: Wilson's disease: a longitudinal study of psychiatric symptoms. Bid Psychiatry 1990; 28:255-265
92. Trautner RJ, Cummings JL, Read SL, Benson DF: Idiopathic basal ganglia calcification and organic mood disorder. Am J Psychiatry 1988; 145:350-353
93. Peyser CE, Folstein SE: Huntington's disease as a model for mood disorders. Mol Chem Neuropathol 1990; 12:99-119
94. Alexander GE, DeLong MR, Strick PL: Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 1986; 9:357-381
95. Bhatia KP, Marsden CD: The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 1994; 117:859-876
96. Starkstein SE, Robinson RG, Berthier ML, Parikh RM, Price TR: Differential mood changes following basal ganglia vs thalamic lesions. Arch Neurol 1988; 45:725-730
97. Cummings JL: Frontal-subcortical circuits and human behavior. Arch Neurol 1993; 50:873-880
98. Laplane D, Levasseur M, Pillon B, Dubois B, Baulac M, Mazoyer B, Tran Dinh S, Sette G, Danze F, Baron JC: Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions: a neuropsychological, magnetic resonance imaging and positron tomography study. Brain 1989; 112:699-725
99. Coffey CE, Figiel GS, Djang WT, Weiner RD: Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects. Am J Psychiatry 1990; 147:187-189
100. Dupont RM, Jernigan TL, Gillin JC, Butters N, Delis DC, Hesselink JR: Subcortical signal hyperintensities in bipolar patients detected by MRI. Psychiatry Res 1987; 21:357-358
101. Figiel GS, Krishnan KR, Rao VP, Doraiswamy M, Ellinwood EH Jr, Nemeroff CB, Evans D, Boyko O: Subcortical hyperintensities on brain magnetic resonance imaging: a comparison of normal and bipolar subjects. J Neuropsychiatry Clin Neurosci 1991; 3:18-22
102. Hickie I, Scott E, Mitchell P, Wilhelm K, Austin MP, Bennett B: Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 1995; 37:151-160
103. Krishnan KRR, Goli V, Ellinwood EH, France RD, Blazer DG, Nemeroff CB: Leukoencephalopathy in patients diagnosed as major depressive. Biol Psychiatry 1988; 23:519-522
104. McDonald WM, Krishnan KRR, Doraiswamy PM, Blazer DG: Occurrence of subcortical hyperintensities in elderly subjects with mania. Psychiatry Res Neuroimaging 1991; 40:211-220
105. Husain MM, McDonald WM, Doraiswamy PM, Figiel GS, Na C, Escalone PR, Boyko OB, Nemeroff CB, Krishnan KRR: A magnetic resonance imaging study of putamen nuclei in major depression. Psychiatry Res Neuroimaging 1991; 40:95-99
106. Krishnan KRR, McDonald WM, Escalone PR, Doraiswamy PM, Na C, Husain MM, Figiel GS, Boyko OB, Ellinwood EH, Nemeroff CB: Magnetic resonance imaging of the caudate nucleus in depression. Arch Gen Psychiatry 1992; 49:553-557
107. Aylward EH, Roberts-Twillie JV, Barta PE, Kumar AJ, Harris GJ, Geer M, Peyser CE, Pearlson GD: Basal ganglia volumes and white matter hyperintensities in patients with bipolar disorder. Am J Psychiatry 1994; 151:687-693
108. Baxter LR, Phelps ME, Mazziotta JC, Schwartz JM, Gerner RH, Selin CE, Sumida RM: Cerebral metabolic rates for glucose in mood disorders. Arch Gen Psychiatry 1985; 42:441-447
109. Buchsbaum MS, Wu J, DeLisi LE, Holcomb H, Kessler R, Johnson J, King AC, Hazlett E, Langston K, Post RM: Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affect Disord 1986; 10:137-152
110. Drevets WC, Raichle ME: Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmacol Bull 1992; 28:261-274
111. Hagman JO, Buchsbaum MS, Wu JC, Rao SJ, Reynolds CA, Blinder BJ: Comparison of regional cerebral brain metabolism in bulimia nervosa and affective disorder assessed with positron emission tomography. J Affect Disord 1990; 19:153-162
112. Mayberg HS, Jeffery PJ, Wagner HN, Simpson SG: Regional cerebral blood flow in patients with refractory unipolar depression measured with Tc-99m HMPAO SPECT. J Nucl Med 1991;32(suppl):951
113. Bench CJ, Friston KJ, Brown RG, Scott L, Frackowiak RSJ, Dolan RJ: The anatomy of melancholia: abnormalities of regional cerebral blood flow in major depression. Psychol Med 1992; 22:607-615
114. Ketter TA, Andreason PJ, George MS, Post RM, DeLisi LE, Uhde TW, Cohen R, Buchsbaum MS: Blunted cerebral blood flow response to procaine in mood disorders, in New Research Program and Abstracts of the 146th Annual Meeting of the American Psychiatric Association. Washington, DC, APA, 1993
115. Baxter LR, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, Gerner RH, Sumida RM: Reduction of prefrontal cortex metabolism common to three types of depression. Arch Gen Psychiatry 1989; 46:243-250
116. Cohen RM, Semple WE, Gross M, Nordahl TE, King AC, Pickar D, Post RM: Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. Neuropsychopharmacology 1989; 2:241-254
117. Martinet J-L, Hardy P, Feline A, Huret J-D, Mazoyer B, Attar-Levy D, Pappata S, Syrota A: Left prefrontal glucose hypometabolism in the depressed state: a confirmation. Am J Psychiatry 1990; 147:1313-1317
118. Post RM, DeLisi LE, Holcomb HH, Uhde TW, Cohen R, Buchsbaum MS: Glucose utilization in the temporal cortex of affectively ill patients: positron emission tomography. Biol Psychiatry 1987; 22:545-553
119. Mayberg HS, Lewis PJ, Regenold W, Wagner HN Jr: Paralimbic hypoperfusion in unipolar depression. J Nucl Med 1994; 35: 929-934
120. Bench CJ, Friston KJ, Brown RG, Frackowiak RS, Dolan RJ: Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol Med 1993; 23:579-590
121. Liddle PF, Friston KJ, Frith CD, Hirsch SR, Jones T, Frackowiak RS: Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 1992; 160:179-186
122. Goldman-Rakic PS: Circuitry of primate prefrontal cortex and regulation of behaviour by representational memory, in Handbook of Physiology - The Nervous System, V. Edited by Mountcastle VB, Plum F, Geiger SR. Bethesda, Md, American Physiological Society, 1987, pp 373-417
123. Dolan RJ, Bench CJ, Brown RG, Scott LC, Friston KJ, Frackowiak RS: Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment. J Neurol Neurosurg Psychiatry 1992; 55:768-773
124. Martin J: Neuroanatomy Text and Atlas. Norwalk, Conn, Appleton & Lange, 1989
125. Carllson A: The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol Rev 1959; 11:490-493
126. Meltzer HY: The importance of serotonin-dopamine interactions in the action of clozapine. Br J Psychiatry Suppl 1992; 17:22-29
127. Meltzer HY, Nash JF: Effects of antipsychotic drugs on serotonin receptors. Pharmacol Rev 1991; 42:587-604
128. Moghaddam B, Bunney BS: Acute effects of typical and atypical antipsychotic drugs on the release of dopaminc from prefrontal cortex, nucleus acumbens, and striatum of the rat: an in vivo microdialysis study. J Neurochem 1990; 54:1755-1760
129. Brown AS, Gershon S: Dopamine and depression. J Neural Transm 1993; 91:75-109
130. Gjerris A, Werdelin L, Rafaelsen OJ, Alling C, Christensen NJ: CSF dopamine increased in depression: CSF dopaminc, noradrenaline and their metabolites in depressed patients and in controls. J Affect Disord 1987; 13:279-286
131. Gjerris A: Do concentrations of neurotransmirters in lumbar CSF reflect cerebral dysfunction in depression? Acta Psychiatr Scand Suppl 1988; 345:21-24
132. Reddy PL, Khanna S, Subhash MN, Channabasavanna SM, Rao BS: CSF amine metabolites in depression. Biol Psychiatry 1992; 31:112-118
133. Roy A, Pickar D, Linnoila M, Doran AR, Ninan P, Paul SM: Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia. Psychiatry Res 1985; 15:281-292
134. Markianos M, Alevizos B, Hatzimanolis J, Stefanis C: Effects of monoamine oxidase A inhibition on plasma biogenic amine metabolites in depressed patients. Psychiatry Res 1994; 52:259-264
135. Wolfe N, Katz DI, Albert ML, Almozlino A, Durso R, Smith MC, Volicer L: Neuropsychological profile linked to low dopamine: in Alzheimer's disease, major depression, and Parkinson's disease. J Neurol Neurosurg Psychiatry 1990; 53:915-917
136. Carr V, Edwards J, Prior M: Urinary MHPG, platelet 3H-imipramine binding and symptomatology in depression: an exploratory study of clinical heterogeneity. Biol Psychiatry 1988; 23: 560-574
137. Maes M, Meltzer HY, Suy E, Minner B, Calabrese J, Cosyns P: Sleep disorders and anxiety as symptom profiles of sympatho-adrenal system hyperactivity in major depression. J Affect Disord 1993; 27:197-207
138. Nair NP, Sharma M: Neurochemical and receptor theories of depression. Psychiatr J Univ Ottawa 1989; 14:328-341
139. Rampello L, Nicoletti G, Raffaele R: Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses. Acta Psychiatr Scand 1991; 84:552-554
140. Kabins D, Gershon S: Potential applications for monoamine oxidase B inhibitor. Dementia 1990; 1:323-348
141. Rudorfer MV, Golden RN, Potter WZ: Second-generation antidepressants. Psychiatr Clin North Am 1984; 7:519-534
142. Goodnick PJ, Extein IL: Bupropion and fluoxetine in depressive subtypes. Ann Clin Psychiatry 1989; 1:119-122
143. Goldstein BJ, Brauzer B, Kentsmith D, Rosenthal S, Charalampous KD: Double-blind placebo-controlled mulricenter evaluation of the efficacy and safety of nomifensine in depressed outpatients. J Clin Psychiatry 1984; 45:52-55
144. Feighner JP, Merideth CH, Claghorn JL: Multicenter placebocontrolled evaluation of nomifensine treatment in depressed outpatients. J Clin Psychiatry 1984; 45(4, part 2):47-51
145. Klerman GL: The evolution of a scientific nosology, in Schizophrenia: Science and Practice. Edited by Shershow JC. Cambridge, Mass, Harvard University Press, 1978, pp 99-121
146. Ghez C: Voluntary movement, in Principles of Neural Science, 3rd ed. Edited by Kandel ER, Schwartz JH, Jessell TM. Norwalk, Conn, Appleton & Lange, 1991, pp 626-646